A nationally recognized leader in reducing hospital infection rates, Dr. Muto's research interests include the control of antibiotic-resistant organisms, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and Clostridium difficile. She has also studied the use of electronic surveillance to identify important pathogens and the effects of mandatory public reporting of hospital-acquired infections. As a result of her groundbreaking work, she has been invited to lecture around the world on effective infection control strategies.
Dr. Muto chairs the Society for Health-Care Epidemiology of America's (SHEA) Antibiotic Resistance Task Force and was the first author of the SHEA Guideline on Preventing Spread of Antibiotic Resistance. She is also a member of and medical advisor to the Southwestern Pennsylvania Professionals in Infection Control (SWPPIC) Regional MRSA Prevention Collaborative.
She was recruited to UPMC in July 1999 from the University of Virginia, where she received a master's degree in health evaluation sciences and completed her infection control training. She received her medical degree in 1993 fromTemple University School of Medicine.